Daily Position Changes Report for ARK Innovation ETF (ARKK)
Date: December 10, 2025
Comparison Date: December 9, 2025
Overview
On December 10, 2025, the ARK Innovation ETF (ARKK) exhibited notable trading activity, with significant changes in the positions of key holdings. The most significant movements were observed in Tesla Inc (TSLA) and Coinbase Global Inc-A (COIN), indicating a strategic shift in the portfolio allocation.
Detailed Summary
The ARKK ETF saw a decrease in its position in Tesla Inc (TSLA), with a reduction in both share value and portfolio weight. Conversely, Coinbase Global Inc (COIN) experienced a slight increase in its portfolio weight, reflecting a potential bullish outlook from ARK Invest. Other notable changes include adjustments in the holdings of CRISPR Therapeutics AG (CRSP) and Tempus AI Inc-A (TEM), which also saw fluctuations in their respective weights and values.
Position Changes Table
| Ticker | Company Name | Direction | Shares Traded | Estimated Trade Value ($) | % of Portfolio Change |
|---|---|---|---|---|---|
| TSLA | Tesla Inc | Sell | - | -463,796.58 | -0.549 |
| COIN | Coinbase Global Inc-A | Buy | - | +1,600,199.10 | +0.038 |
| CRSP | CRISPR Therapeutics AG | Sell | - | -805,389.44 | -0.018 |
| TEM | Tempus AI Inc-A | Buy | - | +1,105,951.79 | +0.083 |
| ROKU | Roku Inc-A | Sell | - | -405,916.72 | -0.002 |
| SHOP | Shopify Inc-A | Buy | - | +1,756,591.54 | +0.011 |
| HOOD | Robinhood Markets Inc-A | Sell | - | -601,672.32 | -0.004 |
| RBLX | Roblox Corp-A | Buy | - | +1,442,214.20 | +0.019 |
| PLTR | Palantir Technologies Inc | Buy | - | +6,543,941.37 | +0.094 |
Analysis and Interpretation
The decrease in Tesla's position may suggest a tactical reallocation of resources by ARK Invest, possibly in response to recent market dynamics or internal performance metrics. The increase in Coinbase's weight, albeit modest, could indicate a renewed confidence in the cryptocurrency sector, aligning with ARK's long-term investment thesis.
The trading activity reflects ARK's ongoing strategy to capitalize on growth opportunities while managing risk. The adjustments in holdings of CRISPR and Tempus indicate a nuanced approach to maintaining a balanced portfolio, focusing on sectors with high growth potential while trimming positions that may not align with current market conditions.
This report will be updated daily to reflect ongoing changes and will include a comprehensive weekly summary every Saturday.
Explore more exclusive insights at nextfin.ai.
